Clinical Use of Biomarkers in Cardiac Amyloidosis

被引：2
|
作者：
Lalario, Andrea [1 ,2 ]
Saro, Riccardo [1 ,2 ]
Sinagra, Gianfranco [1 ,2 ]
Merlo, Marco [1 ,2 ]
Porcari, Aldostefano [1 ,2 ,3 ]
机构：
[1] Univ Trieste, Azienda Sanit Univ Giuliano Isontina ASUGI, Cardiovasc Dept, Ctr Diag & Treatment Cardiomyopathies, Via P Valdoni 7, I-34100 Trieste, Italy
[2] European Reference Network Rare Low Prevalence & C, ERN Guard Heart, Via P Valdoni 7, I-34100 Trieste, Italy
[3] UCL, Div Med, Natl Amyloidosis Ctr, Royal Free Campus,Rowland Hill St, London NW3 2PF, England
来源：
HEART FAILURE CLINICS | 2024年 / 20卷 / 03期
关键词：
Amyloidosis; Transthyretin; Light chains; Biomarkers; Diagnosis; Prognosis; Treatment; LIGHT-CHAIN AMYLOIDOSIS; SERUM TRANSTHYRETIN LEVELS; BINDING-PROTEIN; 4; SYSTEMIC AMYLOIDOSIS; AL AMYLOIDOSIS; DIAGNOSIS; SURVIVAL; DISEASE; INVOLVEMENT; DEFINITION;
D O I：
10.1016/j.hfc.2024.03.001
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：283 / 294
页数：12
相关论文
共 50 条
  • [1] Use of biomarkers to diagnose and manage cardiac amyloidosis
    Castiglione, Vincenzo
    Franzini, Maria
    Aimo, Alberto
    Carecci, Alessandro
    Lombardi, Carlo Mario
    Passino, Claudio
    Rapezzi, Claudio
    Emdin, Michele
    Vergaro, Giuseppe
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 (02) : 217 - 230
  • [2] Utility of Biomarkers in Cardiac Amyloidosis
    Pregenzer-Wenzler, Arianna
    Abraham, Jo
    Barrell, Kelsey
    Kovacsovics, Tibor
    Nativi-Nicolau, Jose
    JACC-HEART FAILURE, 2020, 8 (09) : 701 - 711
  • [3] Cardiac Amyloidosis with Normal Wall Thickness: Prevalence, Clinical Characteristics and Outcome in a Retrospective Analysis
    Nagy, Daniella
    Revesz, Katalin
    Pesko, Gergely
    Varga, Gergely
    Horvath, Laura
    Farkas, Peter
    Toth, Andras David
    Sepp, Robert
    Vago, Hajnalka
    Nagy, Aniko Ilona
    Masszi, Tamas
    Pozsonyi, Zoltan
    BIOMEDICINES, 2022, 10 (07)
  • [4] Multimodal Imaging and Biomarkers in Cardiac Amyloidosis
    Jung, Mi-Hyang
    Chang, Suyon
    Han, Eun Ji
    Youn, Jong-Chan
    DIAGNOSTICS, 2022, 12 (03)
  • [5] Epidemiology and clinical manifestations of cardiac amyloidosis
    Bajwa, Farhan
    O'Connor, Ryan
    Ananthasubramaniam, Karthikeyan
    HEART FAILURE REVIEWS, 2022, 27 (05) : 1471 - 1484
  • [6] Mexican position paper for the diagnosis and treatment of cardiac amyloidosis
    Berrios-Barcenas, Enrique A.
    Cigarroa-Lopez, Jose A.
    Cossio-Aranda, Jorge E.
    Vasquez-Ortiz, Zuilma Y.
    Rodriguez-Diez, Gerardo
    Baeza-Herrera, Luis
    Cordero-Cabra, Juan
    Morales-Portano, Julieta
    Alexanderson-Rosas, Erick
    Carvajal-Juarez, Isabel
    Alvarez-Sangabriel, Amada
    Jordan-Rios, Antonio
    Ivey-Miranda, Juan B.
    Escalante-Seyffert, Cecilia
    Grimaldo, Flavio A.
    Hernandez-Reyes, Pablo
    Lainez-Zelaya, Jose S.
    Lara-Vargas, Jorge A.
    Meave-Gonzalez, Aloha
    Ibarra-Ibarra, Blanca R.
    Koretzky, Solange G.
    Magana-Serrano, Antonio
    ARCHIVOS DE CARDIOLOGIA DE MEXICO, 2024, 94 : 1 - 33
  • [7] Cardiac Amyloidosis
    Gertz, Morie A.
    HEART FAILURE CLINICS, 2022, 18 (03) : 479 - 488
  • [8] Cardiac amyloidosis
    Giorgetti, Assuero
    Genovesi, Dario
    Milan, Elisa
    Acampa, Wanda
    Giubbini, Raffaele
    Cuocolo, Alberto
    Marzullo, Paolo
    CLINICAL AND TRANSLATIONAL IMAGING, 2019, 7 (01) : 21 - 32
  • [9] Cardiac amyloidosis: the need for early diagnosis
    Oerlemans, M. I. F. J.
    Rutten, K. H. G.
    Minnema, M. C.
    Raymakers, R. A. P.
    Asselbergs, F. W.
    de Jonge, N.
    NETHERLANDS HEART JOURNAL, 2019, 27 (11) : 525 - 536
  • [10] A review of recent clinical trials to evaluate disease-modifying therapies in the treatment of cardiac amyloidosis
    Senigarapu, Sindhuja
    Driscoll, James J.
    FRONTIERS IN MEDICINE, 2024, 11
12345